凝血病
败血症
急性肾损伤
急性肾小管坏死
医学
缺氧(环境)
重症监护医学
器官功能障碍
发病机制
肾脏替代疗法
弥漫性血管内凝血
肾
炎症
内皮功能障碍
HMGB1
免疫学
内科学
病理
化学
有机化学
氧气
作者
Toshiaki Iba,Julie Helms,Cheryl L. Maier,Marcel Levi,Ecaterina Scărlătescu,Jerrold H. Levy
标识
DOI:10.1016/j.jtha.2024.02.006
摘要
Inflammation and coagulation are critical self-defense mechanisms for mitigating infection that can nonetheless induce tissue injury and organ dysfunction. In severe cases, like sepsis, a dysregulated thromboinflammatory response may result in multiorgan dysfunction. Sepsis-associated acute kidney injury (AKI) is a significant contributor to patient morbidity and mortality. The connection between AKI and thromboinflammation is largely due to unique aspects of the renal vasculature. Specifically, the interaction between blood cells with the endothelial, glomerular, and peritubular capillary systems during thromboinflammation reduces oxygen supply to tubular epithelial cells. Previous studies have focused on tubular epithelial cell damage due to hypoxia, oxidative stress, and nephrotoxins. Although these factors are pivotal in acute tubular injury or necrosis, recent studies have demonstrated that AKI in sepsis encompasses a mixture of tubular and glomerular damage subtypes. In cases of sepsis-induced coagulopathy, thromboinflammation within the glomerulus and peritubular capillaries is an important pathogenic mechanism for AKI. Unfortunately, and despite the use of renal replacement therapy, the development of AKI in sepsis continues to be associated with high morbidity, mortality, and clinical challenges requiring alternative approaches. This review introduces the important role of thromboinflammation in AKI pathogenesis and details innovative vascular-targeting therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI